Moreau P, Garfall AL, van de Donk N, Nahi H, San-Miguel JF, Oriol A, et al. Teclistamab in relapsed or refractory multiple myeloma. N Engl J Med. 2022;387:495–505.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lesokhin AM, Tomasson MH, Arnulf B, Bahlis NJ, Prince HM, Niesvizky R, et al. Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results. Nat Med. 2023;29:2259–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

D’Souza A, Shah N, Rodriguez C, Voorhees PM, Weisel K, Bueno OF, et al. A phase I first-in-human study of ABBV-383, a B-cell maturation antigen × CD3 bispecific T-cell redirecting antibody, in patients with relapsed/refractory multiple myeloma. J Clin Oncol. 2022;40:3576–86.

Article  PubMed  PubMed Central  Google Scholar 

Palladini G, Merlini G. How I treat AL amyloidosis. Blood. 2022;139:2918–30.

Article  CAS  PubMed  Google Scholar 

Merlini G. AL amyloidosis: from molecular mechanisms to targeted therapies. Hematology. 2017;2017:1–12.

Article  PubMed  PubMed Central  Google Scholar 

Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HS, et al. Daratumumab-based treatment for immunoglobulin light-chain amyloidosis. N Engl J Med. 2021;385:46–58.

Article  CAS  PubMed  Google Scholar 

Palladini G, Dispenzieri A, Gertz MA, Kumar S, Wechalekar A, Hawkins PN, et al. New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes. J Clin Oncol. 2012;30:4541–9.

Article  CAS  PubMed  Google Scholar 

Manwani R, Cohen O, Sharpley F, Mahmood S, Sachchithanantham S, Foard D, et al. A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib. Blood. 2019;134:2271–80.

Article  CAS  PubMed  Google Scholar 

Leung NCJ, Bhatia S. First report of teclistamab in a patient with relapsed AL amyloidosis and multiple myeloma. EJHaem. 2023;4:1157–9.

Article  PubMed Central  Google Scholar 

Sanchorawala V, Shelton AC, Lo S, Varga C, Sloan JM, Seldin DC. Pomalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 1 and 2 trial. Blood. 2016;128:1059–62.

Article  CAS  PubMed  Google Scholar 

Dispenzieri A, Buadi F, Laumann K, LaPlant B, Hayman SR, Kumar SK, et al. Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis. Blood. 2012;119:5397–404.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sanchorawala V, Palladini G, Kukreti V, Zonder JA, Cohen AD, Seldin DC, et al. A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis. Blood. 2017;130:597–605.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dispenzieri A, Kastritis E, Wechalekar AD, Schonland SO, Kim K, Sanchorawala V, et al. A randomized phase 3 study of ixazomib-dexamethasone versus physician’s choice in relapsed or refractory AL amyloidosis. Leukemia. 2022;36:225–35.

Article  CAS  PubMed  Google Scholar 

Lentzsch S, Lagos GG, Comenzo RL, Zonder JA, Osman K, Pan S, et al. Bendamustine With dexamethasone in relapsed/refractory systemic light-chain amyloidosis: results of a phase II study. J Clin Oncol. 2020;38:1455–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Premkumar VJ, Lentzsch S, Pan S, Bhutani B, Richter J, Jagannath S, et al. Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis. Blood Cancer J. 2021;11:10.

Article  PubMed  PubMed Central  Google Scholar 

Hammons L, Szabo A, Janardan A, Bhatlapenumarthi V, Annyapu E, Dhakal B, et al. The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma. Haematologica. 2023. https://doi.org/10.3324/haematol.2023.283590.

Hammons LR, Szabo A, Janardan A, Dhakal B, Chhabra S, D’Souza A, et al. Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple Myeloma. JAMA Netw Open. 2022;5:e2238961.

Article  PubMed  PubMed Central  Google Scholar